| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.001 |